A detailed history of Westbourne Investments, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Westbourne Investments, Inc. holds 82,475 shares of PFE stock, worth $2.07 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
82,475
Previous 81,595 1.08%
Holding current value
$2.07 Million
Previous $1.98 Billion 2.79%
% of portfolio
0.97%
Previous 1.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$23.29 - $25.88 $20,495 - $22,774
880 Added 1.08%
82,475 $2.03 Billion
Q2 2025

Jul 09, 2025

SELL
$21.59 - $24.84 $292,976 - $337,078
-13,570 Reduced 14.26%
81,595 $1.98 Billion
Q1 2025

May 21, 2025

BUY
$25.01 - $27.13 $2.38 Million - $2.58 Million
95,165 New
95,165 $2.41 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Westbourne Investments, Inc. Portfolio

Follow Westbourne Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investments, Inc. with notifications on news.